医薬品市場とMR数、そして生産性の相関関係を検討してみました。

MR数の増減と生産性の間には非常に強い相関が認められました。

MR数の増減と国内医薬品市場の間にはほとんど相関がありませんでした。

国民医療費の増減と医薬品市場は強い相関が認められます。

つまり、医薬品の売上額が増加すれば国民医療費が増大し、その医薬品の売上にはMR数はあまり寄与していないという結果です。

ならばMR数を減らして生産性を向上させることは正しい選択といえそうですがいかがでしょうか。

“What are the driving factors behind the pharmaceutical market? ”

We examined the correlation between the number of MRs, pharmaceutical market, and productivity in the pharmaceutical industry.

A significant correlation was found between the changes in the number of MRs and productivity.

However, there was little correlation between the changes in the number of MRs and the domestic pharmaceutical market.

On the other hand, there was a strong correlation between the fluctuations in national healthcare expenditure and the pharmaceutical market.

In other words, an increase in pharmaceutical sales leads to a rise in national healthcare expenditure, but the number of MRs does not seem to contribute significantly to the sales of pharmaceutical products. Considering these results, reducing the number of MRs to improve productivity appears to be a viable option.